Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Assessing intracortical myelin in the living human brain using myelinated cortical thickness.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Concomitant granule cell neuronopathy in patients with natalizumab-associated PML.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Effect of occupation on risk of developing MS: an insurance cohort study.
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
P300 wave changes in patients with multiple sclerosis.
Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases.
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Seizure in Iranian patients with multiple sclerosis.
Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR-CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Microglia and neuroprotection.
A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.

Pages